81480 Federal Register / Vol. 85, No. 242 / Wednesday, December 16, 2020 / Notices 

7W108, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Wlodek Lopaczynski, 

M.D., Ph.D., Assistant Director, Office of the 

Director, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W514, Rockville, 

Maryland 20850, 240–276–6458 lopacw@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Feasibility 

to Build Collaborative Partnerships in Cancer 

research. 

Date: February 10, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W108, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Rockville, Maryland 20850, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

F—Institutional Training and Education. 

Date: February 24–25, 2021. 

Time: 9:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W234, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review, Branch Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609 Medical Center Drive, 

Room 7W234 Rockville, Maryland 20850, 

240–276–6368, Stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Feasibility 

and Planning Studies for SPOREs in Cancer 

Health Disparities. 

Date: February 25–26, 2021. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W126, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Caron A. Lyman, Ph.D., 

Chief, Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W126, Rockville, Maryland 20850, 

240–276–6348, lymanc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group Subcommittee; 

J-Career Development. 

Date: February 25–26, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W624, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Tushar Deb, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W624, Rockville, Maryland 20850, 

240–276–6132, tushar.deb@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Cancer 

Biomarkers and Biospecimens. 

Date: February 26, 2021. 

Time: 12:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W106, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Reed A. Graves, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W106, Rockville, Maryland 

20850, 240–276–6384, gravesr@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–8A: 

SBIR Contract Review Meeting. 

Date: March 16, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W246, Rockville, Maryland 20850, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP 

Training Grants 

Date: March 16, 2021. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove. 9609 Medical Center Drive, Room 

7W234. Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W234, Rockville, Maryland 20850, 

240–276–6368, stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–8B: 

SBIR Contract Review Meeting. 

Date: March 18, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W246, Rockville, Maryland 20850, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Information Technology in Cancer Research. 

Date: March 30–31, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W234, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W234, Rockville, Maryland 20850, 

240–276–6368, Stoicaa2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 12, 2020. 

Patricia B. Hansberger, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2020–27625 Filed 12–15–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Aging and 

Balance. 

Date: February 18, 2021. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 242 / Wednesday, December 16, 2020 / Notices 81481 

Place: National Institute on Aging Gateway 

Building, 7201 Wisconsin Avenue, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Greg Bissonette, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Gateway Building, Suite 2W200, Bethesda, 

MD 20892, (301) 402–1622, bissonettegb@

mail.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Drug 

Repositioning and Combination Therapy for 

AD. 

Date: February 23, 2021. 

Time: 12:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging Gateway 

Building, 7201 Wisconsin Avenue, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Alexander Parsadanian, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway 

Building 2C/212, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (301) 496–9666, 

parsadaniana@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 10, 2020. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–27623 Filed 12–15–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; NIAAA Individual 

Fellowships (F30, F31, F32) Review Panel. 

Date: February 24, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700 B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Luis Espinoza, Ph.D., 

Scientific Review Officer, Extramural Project 

Review, Branch Office of Extramural 

Activities, National Institute on Alcohol 

Abuse and Alcoholism, 6700B Rockledge 

Drive, Room 2109, Bethesda, MD 20892, 

(301) 443–8599, espinozala@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards., National 

Institutes of Health, HHS) 

Dated: December 10, 2020. 

Patricia B. Hansberger, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2020–27624 Filed 12–15–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID: FEMA–2020–0039; OMB No. 

1660–0006] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request; National Flood 

Insurance Program Policy Forms 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: 60-Day notice and request for 

comments. 

SUMMARY: The Federal Emergency 

Management Agency, as part of its 

continuing effort to reduce paperwork 

and respondent burden, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on a revision of a currently 

approved information collection. In 

accordance with the Paperwork 

Reduction Act of 1995, this notice seeks 

comments concerning information 

collected for the selling and servicing of 

National Flood Insurance Program 

(NFIP) policies by FEMA’s direct 

servicing agent, NFIP Direct. 

DATES: Comments must be submitted on 

or before February 16, 2021. 

ADDRESSES: Submit comments at 

www.regulations.gov under Docket ID 

FEMA–2020–0039. Follow the 

instructions for submitting comments. 

All submissions received must 

include the agency name and Docket ID, 

and will be posted, without change, to 

the Federal eRulemaking Portal at 

http://www.regulations.gov, and will 

include any personal information you 

provide. Therefore, submitting this 

information makes it public. You may 

wish to read the Privacy and Security 

Act Notice that is available via a link on 

the homepage of www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Joycelyn Collins, Underwriting Branch 

Program Analyst, Federal Insurance 

Directorate, 202–701–3383. You may 

contact the Records Management 

Division for copies of the proposed 

collection of information at email 

address: FEMA-Information-CollectionsManagement@fema.dhs.gov. 

SUPPLEMENTARY INFORMATION: The NFIP 

is authorized by Public Law 90–448 

(1968) and expanded by Public Law 93– 

234 (1973). The National Flood 

Insurance Act of 1968 requires that the 

Federal Emergency Management Agency 

(FEMA) provide flood insurance at full 

actuarial rates reflecting the complete 

flood risk to structures built or 

substantially improved on or after the 

effective date for the initial Flood 

Insurance Rate Map for the community, 

or after December 31, 1974, whichever 

is later, so that the risks associated with 

buildings in flood-prone areas are borne 

by those located in such areas and not 

by the taxpayers at large. In accordance 

with Public Law 93–234, the purchase 

of flood insurance is mandatory when 

Federal or federally-related financial 

assistance is being provided for 

acquisition or construction of buildings 

located, or to be located, within FEMAidentified special flood hazard areas of 

communities that participate in the 

NFIP. 

Collection of Information 

Title: National Flood Insurance 

Program Policy Forms. 

Type of Information Collection: 

Revision of a currently approved 

information collection. 

OMB Number: 1660–0006. 

FEMA Forms: FEMA Forms 086–0–1 

and 086–0–1T, Flood Insurance 

Application; FEMA Forms 086–0–2 and 

086–0–2T, Flood Insurance 

Cancellation/Nullification Request 

Form; FEMA Forms 086–0–3 and 086– 

3T, Flood Insurance General Change 

Endorsement; FEMA Form 086–0–4, VZone Risk Factor Rating Form and 

Instructions (discontinued October 16, 

2019, due to insufficient use); and 

FEMA Form 086–0–5T, Flood Insurance 

Preferred Risk Policy and Newly 

Mapped Application. 


khammond on DSKJM1Z7X2PROD with NOTICES